3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
2
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor
Conditions
Motor Activity
10
Neoplasms
8
Breast Neoplasms
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Disease
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Psychological Well-Being
1
Prostatic Neoplasms
1
Personal Satisfaction
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Muscular Atrophy
1
Mesothelioma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Esophageal Neoplasms
1
Edema
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cancer Patients
1
Cachexia
1
Breast Cancer Survivors
1
Breast Cancer Lymphedema
1
Interventions
Standard of Care
1
Rosuvastatin Calcium
1
Rehabilitation
1
Diagnostic Imaging
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cardiotoxicity
×
Exercise
×
Clear all
No trials found.